Crucial Architectures: Structural Considerations in the Development of Hsp90 Alpha Inhibitors for Cancer Therapeutics

EasyChair Preprint no. 11711

Abstract

As the quest for more effective cancer therapeutics continues, understanding the intricate molecular architectures that govern the design of Hsp90 alpha inhibitors emerges as a pivotal aspect in precision medicine. This research endeavors to explore the structural considerations integral to the development of Hsp90 alpha inhibitors, aiming to unravel the key molecular architectures that confer efficacy in cancer treatment. The investigation delves into the structural motifs, binding domains, and dynamic interactions that define the success of Hsp90 alpha inhibitors as cancer therapeutics. By scrutinizing the nuanced relationship between structure and function, this study aims to provide insights into how specific architectural elements contribute to the inhibitors' potency, selectivity, and mechanism of action.

Keyphrases: alpha, Hsp90, Inhibitors

@Booklet{EasyChair:11711,
  author = {Kurez Oroy and Patrick Evan},
  title = {Crucial Architectures: Structural Considerations in the Development of Hsp90 Alpha Inhibitors for Cancer Therapeutics},
  howpublished = {EasyChair Preprint no. 11711},

  year = {EasyChair, 2024}}